Thomas Horn, MD
Plastic Surgery · Savannah, GANPI 1184786139
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,126 of the $4,723 with a category attached, or 66.2%. AbbVie accounts for 77.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $3,677 and has fallen 96.3% since, to $136 in 2025.
Across 68 payments — averaging $69.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Mentor Worldwide LLC$853
- Zimmer Biomet$53
- Axogen$33
- Musculoskeletal Transplant Foundation Inc.$27
- Osiris Therapeutics Inc.$24
- plus $91 from 6 others
What the payments were for
- Travel & lodging$3,12666%
- Food & beverage$1,59734%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $3,641 |
| Mentor Worldwide LLC | 41 | $853 |
| Zimmer Biomet | 1 | $53 |
| Axogen | 1 | $33 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $27 |
| Osiris Therapeutics Inc. | 1 | $24 |
| Globus Medical | 1 | $22 |
| TELA Bio, Inc. | 1 | $19 |
| Aroa Biosurgery Incorporated | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Molnlycke Health Care US, LLC | 1 | $12 |
| Smith+Nephew | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,723 in reported general payments places this provider in the 65th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 161 | $865 |
| Doxycycline Monohydrate | 79 | $765 |
| Cephalexin | 115 | $652 |
| Ondansetron OdtOndansetron | 34 | $354 |
| Cyclobenzaprine Hcl | 67 | $297 |
| Doxycycline Hyclate | 24 | $227 |
| Mupirocin | 22 | $128 |
| Ciprofloxacin Hcl | 22 | $117 |
| Tramadol Hcl | 24 | $36 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Savannah
- Anand KumarSavannah$39K
- Richard GrecoSavannah$11K
- Matthew McLeodSavannah$9K
- Luke CurtsingerSavannah$8K
- Carl PearlSavannah$6K
- David ZabelAugusta$511K
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Michael McNeelMarietta$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.